University Of Florence
Clinical trials sponsored by University Of Florence, explained in plain language.
-
Art and talk therapy may ease fibromyalgia pain, new study hopes
Symptom relief Recruiting nowThis study looks at whether a program that combines counseling and museum visits can help people with fibromyalgia, a condition causing widespread pain and emotional distress. Researchers will first assess participants' mental and physical health, then offer a therapy that includ…
Phase: NA • Sponsor: University of Florence • Aim: Symptom relief
Last updated May 17, 2026 03:11 UTC
-
Can a migraine infusion stop pain in its tracks?
Symptom relief Recruiting nowThis study tests whether the drug eptinezumab can quickly stop a migraine attack when given as an IV infusion. Researchers will measure how fast headache pain and other bothersome symptoms go away. The study involves 50 adults with migraine who are already receiving the drug as p…
Sponsor: University of Florence • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New study aims to ease migraine pain quickly
Symptom relief Recruiting nowThis study is testing how well the drug rimegepant works for treating migraine attacks in 100 adults with episodic or chronic migraine. Researchers will measure pain relief two hours after taking the drug and track any side effects. The goal is to see if rimegepant is effective a…
Sponsor: University of Florence • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Talking your way out of migraine pain? new study tests Well-Being therapy
Symptom relief Recruiting nowThis study tests a short talk therapy called Well-Being Therapy (WBT) for people with chronic migraine. The goal is to see if it can reduce migraine-related disability, pain, and distress while boosting overall well-being. About 30 adults with chronic migraine will receive either…
Phase: NA • Sponsor: University of Florence • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC
-
New hope for migraine sufferers: rimegepant under study
Symptom relief Recruiting nowThis study looks at how well and how safely the drug rimegepant works to prevent migraines. About 100 adults with episodic or chronic migraines will take rimegepant for up to 12 months. Researchers will track changes in the number of migraine days per month to see if the drug red…
Sponsor: University of Florence • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC